MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, IVZ has $28,438,900K in assets. $13,646,600K in debts. $973,100K in cash and cash equivalents.

Balance Sheets Overview

Debt to Asset Ratio
47.99%
Assets Breakdown
    • Investments and other assets of ...
    • Goodwill
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Debt and other liabilities of ci...
    • Additional paid-in-capital
    • Retained earnings
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Cash and cash equivalents
973,100 922,700 821,700 986,500
Accounts receivable
810,500 747,100 794,600 740,800
Investments
1,164,200 1,128,700 1,076,400 1,240,000
Other assets
1,356,200 1,236,300 1,252,000 1,120,700
Property, equipment and software, net
387,700 453,600 458,400 479,000
Intangible assets, net
5,731,200 5,751,300 5,746,600 5,749,300
Goodwill
8,459,800 8,583,300 8,373,000 8,318,100
Investments and other assets of consolidated investment products (cip)
9,556,200 9,673,900 9,620,900 8,374,500
Total assets
28,438,900 28,496,900 28,143,600 27,008,900
Accrued compensation and benefits
893,000 716,400 542,900 1,029,200
Accounts payable and accrued expenses
1,496,200 1,431,800 1,415,700 1,285,300
Debt
1,624,600 1,883,900 964,800 890,600
Deferred tax liabilities, net
1,318,800 1,313,400 1,328,400 1,281,900
Debt and other liabilities of cip
8,314,000 8,192,500 8,104,400 6,853,100
Total liabilities
13,646,600 13,538,000 12,356,200 11,340,100
Redeemable noncontrolling interests in consolidated entities
150,500 531,600 545,500 544,700
Preferred shares (0.20 par value 1,000 liquidation preference 4.0million authorized and issued 3.0million outstanding as of september30, 2025 (december31, 2024 4.0million outstanding)
3,010,500 3,010,500 4,010,500 4,010,500
Common shares (0.20 par value 1,050.0million authorized 566.1 million shares issued as of september30, 2025 and december31, 2024)
113,200 113,200 113,200 113,200
Additional paid-in-capital
7,253,900 7,250,100 7,235,800 7,334,600
Treasury shares
2,803,900 2,797,800 2,781,900 2,852,700
Retained earnings
7,167,600 6,961,300 7,069,000 6,990,400
Accumulated other comprehensive income/(loss), net of tax
-735,700 -664,200 -947,900 -1,036,100
Total equity attributable to invesco ltd
14,005,600 13,873,100 14,698,700 14,559,900
Equity attributable to nonredeemable noncontrolling interests in consolidated entities
636,200 554,200 543,200 564,200
Total permanent equity
14,641,800 14,427,300 15,241,900 15,124,100
Total liabilities, temporary and permanent equity
28,438,900 28,496,900 28,143,600 27,008,900
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investments and other assetsof consolidated...$9,556,200K Goodwill$8,459,800K Intangible assets, net$5,731,200K Property, equipment andsoftware, net$387,700K Other assets$1,356,200K Investments$1,164,200K Accounts receivable$810,500K Cash and cashequivalents$973,100K Total assets$28,438,900K Total liabilities,temporary and permanent...$28,438,900K Total permanentequity$14,641,800K Redeemable noncontrollinginterests in consolidated...$150,500K Total liabilities$13,646,600K Equity attributable tononredeemable noncontrolling...$636,200K Total equityattributable to invesco ltd$14,005,600K Debt and otherliabilities of cip$8,314,000K Deferred taxliabilities, net$1,318,800K Debt$1,624,600K Accounts payable andaccrued expenses$1,496,200K Accrued compensationand benefits$893,000K Accumulated othercomprehensive income/(loss),...-$735,700K Treasury shares$2,803,900K Retained earnings$7,167,600K Additionalpaid-in-capital$7,253,900K Common shares (0.20 parvalue 1,050.0million...$113,200K Preferred shares (0.20 parvalue 1,000...$3,010,500K

IVZ_BIG copy-svg

Invesco Ltd. (IVZ)

IVZ_BIG copy-svg

Invesco Ltd. (IVZ)